DeSnyder, Sarah M.
Yi, Min
Boccardo, Francesco
Feldman, Sheldon
Klimberg, V. Suzanne
Smith, Mark
Thiruchelvam, Paul T. R.
McLaughlin, Sarah
Article History
Received: 27 April 2021
Accepted: 1 July 2021
First Online: 31 July 2021
Disclosure
: Sarah DeSnyder is the principal investigator in a clinical trial funded by ImpediMed for which The University of Texas MD Anderson Cancer Center receives funds from ImpediMed.